Itron (NASDAQ:ITRI) Rating Increased to Buy at Wall Street Zen

Itron (NASDAQ:ITRI) was upgraded by research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research report issued on Saturday.

Several other research analysts also recently commented on the company. Oppenheimer set a $145.00 price objective on Itron and gave the stock an “outperform” rating in a report on Friday. Robert W. Baird reiterated a “neutral” rating and issued a $118.00 price objective (down previously from $137.00) on shares of Itron in a report on Friday. Guggenheim reiterated a “buy” rating and issued a $155.00 price objective (up previously from $133.00) on shares of Itron in a report on Monday, July 14th. Stephens reissued an “equal weight” rating and issued a $130.00 target price on shares of Itron in a research note on Tuesday, October 7th. Finally, Zacks Research raised Itron from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, October 14th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, Itron presently has a consensus rating of “Moderate Buy” and a consensus price target of $139.00.

Itron Stock Down 7.9%

ITRI opened at $100.33 on Friday. The company has a market cap of $4.59 billion, a P/E ratio of 17.15, a P/E/G ratio of 0.76 and a beta of 1.48. The business’s 50-day moving average price is $124.67 and its 200-day moving average price is $122.95. The company has a current ratio of 2.04, a quick ratio of 1.75 and a debt-to-equity ratio of 0.48. Itron has a 12 month low of $90.11 and a 12 month high of $142.00.

Itron (NASDAQ:ITRI) last released its quarterly earnings data on Thursday, October 30th. The scientific and technical instruments company reported $1.54 EPS for the quarter, topping the consensus estimate of $1.48 by $0.06. The firm had revenue of $581.63 million for the quarter, compared to the consensus estimate of $578.49 million. Itron had a return on equity of 19.69% and a net margin of 11.05%.The company’s quarterly revenue was down 5.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.84 earnings per share. Itron has set its FY 2025 guidance at 6.840-6.940 EPS. Q4 2025 guidance at 2.150-2.250 EPS. On average, equities analysts expect that Itron will post 5.33 EPS for the current year.

Insider Activity

In other Itron news, CFO Joan S. Hooper sold 970 shares of the company’s stock in a transaction that occurred on Monday, August 25th. The stock was sold at an average price of $125.31, for a total transaction of $121,550.70. Following the transaction, the chief financial officer owned 88,394 shares in the company, valued at approximately $11,076,652.14. This represents a 1.09% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Donald L. Reeves III sold 547 shares of the company’s stock in a transaction that occurred on Monday, August 25th. The stock was sold at an average price of $125.31, for a total value of $68,544.57. Following the transaction, the senior vice president owned 19,604 shares in the company, valued at $2,456,577.24. This trade represents a 2.71% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 3,037 shares of company stock worth $380,566. Company insiders own 1.45% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Copia Wealth Management purchased a new position in shares of Itron during the 3rd quarter worth approximately $92,000. Whittier Trust Co. purchased a new position in shares of Itron during the 3rd quarter worth approximately $56,000. PFG Investments LLC boosted its position in shares of Itron by 4.8% in the 3rd quarter. PFG Investments LLC now owns 2,059 shares of the scientific and technical instruments company’s stock worth $256,000 after purchasing an additional 94 shares in the last quarter. Resona Asset Management Co. Ltd. bought a new stake in shares of Itron in the 3rd quarter worth approximately $381,000. Finally, UniSuper Management Pty Ltd boosted its position in shares of Itron by 16.5% in the 3rd quarter. UniSuper Management Pty Ltd now owns 31,375 shares of the scientific and technical instruments company’s stock worth $3,908,000 after purchasing an additional 4,451 shares in the last quarter. Hedge funds and other institutional investors own 96.19% of the company’s stock.

About Itron

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.